摘要
射频消融(RFA)是不能耐受外科手术的早期非小细胞肺癌(NSCLC)治疗选择之一,但是仍需要进行前瞻性随机多中心临床研究,比较其它局部治疗手段如亚肺叶切除与立体定向放射治疗(SBRT);同时,早期肺癌RFA后局部复发率较高,需要联合其它肿瘤治疗手段如放疗、化疗和分子靶向药物治疗等提高局部控制率。
Radiofrequency ablation（RFA） is one of the treatment options for inoperable early-stage non-small cell lung cancer（NSCLC）. However, prospective randomized multicenter clinical studies are still necessary to clarify the value of RFA and to compare the therapeutic effect with other local treatments such as sub-lobar resection and stereotactic body radiation therapy（SBRT）. Moreover, as the local recurrence rate of early lung cancer after RFA is high, the combination use of other anti-tumor therapies such as radiotherapy,chemotherapy, molecular targeted drug therapy, etc. are often needed in order to improve the local control rate.
作者
刘宝东
LIU Baodong(Department of Thoracic Surgery,Xuanwu Hospital,Capital Medical University,Beijing 100053,China)
出处
《介入放射学杂志》
CSCD
北大核心
2018年第11期1013-1017,共5页
Journal of Interventional Radiology
关键词
非小细胞肺癌
射频消融
CT
non-small cell lung cancer
radiofrequency ablation
tomography
X-ray computed
